MoonLake Immunotherapeutics (MLTX) Tax Provisions (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) recorded quarterly Tax Provisions of $622000.0 in Q1 2026, up 150.81% quarter-over-quarter from $248000.0 in Q4 2025, and up 306.54% on a YoY basis from $153000.0 in Q1 2025.
MoonLake Immunotherapeutics (MLTX) Tax Provisions (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Tax Provisions history runs 6 years deep, the most recent figure standing at $622000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 306.54% year-over-year to $622000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 195.89% YoY), while the FY2025 annual figure was $611000.0, up 116.67% from the prior year.
- Tax Provisions was $622000.0 for Q1 2026 at MoonLake Immunotherapeutics, up from $248000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $622000.0 in Q1 2026 to a low of $7332.0 in Q1 2022.
- Historically, Tax Provisions has averaged $96786.4 across 5 years, with a median of $43920.0 in 2023.
- Biggest YoY gain for Tax Provisions was 678.4% in 2024; the steepest drop was 6.65% in 2024.
- A 5-year view of Tax Provisions shows it stood at $11012.0 in 2022, then soared by 298.84% to $43920.0 in 2023, then fell by 6.65% to $41000.0 in 2024, then surged by 504.88% to $248000.0 in 2025, then soared by 150.81% to $622000.0 in 2026.
- The last three Tax Provisions figures came in at $622000.0 (Q1 2026), $248000.0 (Q4 2025), and $115000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.27 Bn | 910.04 Mn | - | 622,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 622,000.00 |
| Dec 31, 2025 | 248,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 153,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | 43,920.00 |
| Sep 30, 2023 | 28,923.00 |
| Jun 30, 2023 | 10,149.00 |
| Mar 31, 2023 | 11,010.00 |
| Dec 31, 2022 | 11,012.00 |
| Sep 30, 2022 | 8,740.00 |
| Jun 30, 2022 | 9,282.00 |
| Mar 31, 2022 | 7,332.00 |
| Dec 31, 2021 | 4,755.00 |